Stallion India Fluorochemicals processes, blends, and distributes refrigerant and specialty gases used in air conditioning, automotive, and industrial applications. The company is currently transitioning from a pure distribution and debulking model to a backward-integrated manufacturer of R-32 and other high-purity gases.
The company possesses a narrow moat based on regulatory licenses and a specialized distribution network for hazardous materials. While they claim pricing power, the quant snapshot shows an EPS CAGR of -2.1% despite 28.5% revenue growth, suggesting that high input costs or competitive pressures are currently offsetting their scale advantages.
Management is aggressively reinvesting internal accruals and IPO proceeds into backward integration projects in Rajasthan and Andhra Pradesh. While ROCE is healthy at 21.5%, the negative cash conversion indicates significant capital is being tied up in working capital and long-gestation projects.
The company's aggressive expansion into backward integration projects in Rajasthan and Andhra Pradesh became a capital-intensive trap. Despite rapid revenue growth, the inability to translate sales into earnings—already visible in the negative EPS CAGR—worsened as working capital requirements spiraled out of control. The negative cash conversion cycle forced the company into a liquidity crunch, exacerbated by the failure of planned fundraises and the promoter's desperate open-market sales to keep projects afloat. Ultimately, the specialized distribution network was commoditized by larger players, and the high-cost manufacturing facilities failed to achieve the necessary scale, leaving the company with a bloated balance sheet and no pricing power.
RichFakir rates Stallion India Fluorochemicals Ltd's business quality as mediocre — 53/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Stallion India Fluorochemicals Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Stallion India Fluorochemicals Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Stallion India Fluorochemicals Ltd's fair value is about ₹21 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →